What is AAPG stock price today?

AAPG (Ascentage Pharma Group International) stock is trading at $26.01 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is AAPG stock going up or down today?

AAPG stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy AAPG stock now?

The decision to buy AAPG depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is AAPG a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for AAPG based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is AAPG stock overvalued or undervalued?

Use our DCF valuation calculator to determine if AAPG is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is AAPG's P/E ratio?

P/E ratio data for AAPG will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is AAPG's market cap?

AAPG (Ascentage Pharma Group International) has a market capitalization of $2.53 billion, making it a small-cap stock.

What is AAPG's price to book ratio?

AAPG trades at a price-to-book (P/B) ratio of 26.31, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does AAPG pay dividends?

AAPG does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is AAPG's dividend yield?

AAPG does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is AAPG stock a good long-term investment?

AAPG's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is AAPG's revenue growth rate?

AAPG has shown revenue growth of -0.7% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

AAPG is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in AAPG?

Key risks for AAPG include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does AAPG compare to its competitors?

Compare AAPG to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize AAPG's performance and positioning.

What is AAPG's stock price target for 2026?

Our AI model provides price targets for AAPG based on fundamental analysis: Bull case $33.81 (+30%), Base case $29.91 (+15%), Bear case $23.41 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about AAPG?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for AAPG. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is AAPG's next earnings report?

AAPG reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

AAPG - Ascentage Pharma Group International

NYSE * Health Care * Biotechnology

$26.01

$-1.04 (-3.84%)

About Ascentage Pharma Group International

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin's lymphoma. In addition, the company is developing APG-1387, a small-molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-2449, an oral inhibitor of FAK, ROS1, and ALK kinases; APG-5918, an orally available and selective embryonic ectoderm development inhibitor. In addition, it is involved in medical research and development; clinical development; clinical trials operations; venture capital investment; rental of buildings; and provision of science and technology promotion services. The company has collaboration relationships with biotechnology and pharmaceutical companies; and research institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.

AAPG Key Statistics

Market Cap

$2.53B

P/B Ratio

26.31

EPS

$-2.08

Revenue Growth

-0.7%

Profit Margin

-3.0%

Employees

567

How AAPG Compares to Peers

AAPG is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
AAPG(This stock)	$2.53B	N/A	-1%	-3.0%	-
AMGNAmgen Inc	$178.24B	25.6	0%	0.2%	vs AMGN
GILDGilead Sciences	$154.03B	19.2	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.35B	31.2	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$77.77B	17.6	0%	0.3%	vs REGN
BIIBBiogen Inc	$24.26B	15.1	0%	0.2%	vs BIIB

Ascentage Pharma Group International Company Information

Headquarters: China
Website: www.ascentagepharma.com
Sector: Health Care
Industry: Biotechnology

About Ascentage Pharma Group International

AAPG Key Statistics

How AAPG Compares to Peers

Ascentage Pharma Group International Company Information

Upcoming Events for AAPG